Article
Oncology
R. E. Asberg, M. Nilsen, M. J. Hjermstad, K. V. Reinertsen, J. Karlsen, G. F. Giskeodegard, R. J. Reidunsdatter
Summary: The objective of this study was to provide normative values for the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires QLQ-C30, QLQ-SHQ22, QLQ-BR23, and QLQ-BR45 in the Norwegian general population. A random nationwide sample was drawn, and participants were notified through online health services and postal mail. The results showed that women and individuals with morbidities reported lower functioning and higher symptom burden. The study highlights the importance of considering age, sex, and morbidity when assessing health-related quality of life.
EUROPEAN JOURNAL OF CANCER
(2023)
Article
Surgery
Y. J. Liu, A. Schandl, S. Markar, A. Johar, P. Lagergren
Summary: Patients undergoing oesophageal cancer surgery are at higher risk of psychological distress and reduced HRQoL. This study showed that psychological distress was associated with various aspects of poor HRQoL for up to 2 years after surgery, including emotional function, social function, and physical symptoms.
Article
Oncology
Quirien Oort, Hanneke Zwinkels, Johan A. F. Koekkoek, Maaike J. Vos, Jaap C. Reijneveld, Martin J. B. Taphoorn, Linda Dirven
Summary: This study evaluated the effectiveness of using the EORTC QLQ-C30 Emotional Functioning scale as a screening measure for mood disorders in glioma patients. The results showed a strong correlation with the Hospital Anxiety and Depression Scale and demonstrated good discriminating capabilities, making it a suitable tool for identifying patients at risk of mood disorders.
Article
Multidisciplinary Sciences
Verena Schadewaldt, Sandhya Cherkil, Dilip Panikar, Katharine J. Drummond
Summary: This study compared health-related quality of life and symptom burden in meningioma patients from Australia and India postoperatively. Despite some differences, clinically meaningful differences between the two groups were not common.
Article
Gastroenterology & Hepatology
Asia Avinir, Shire Dar, Michel Taler, Ola Haj, Doron Gothelf, Uri Kopylov, Shomron Ben-Horin, Ehud Mekori-Domachevsky
Summary: Depression and anxiety are common in IBD patients and can worsen prognosis. The HADS was found to be a valid screening tool for anxiety and depression, with recommendations to use it routinely in GI follow-ups, adjusting the cut-off scores for depression and anxiety.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY
(2021)
Article
Gastroenterology & Hepatology
Asia Avinir, Shira Dar, Michal Taler, Ola Haj, Doron Gothelf, Uri Kopylov, Shomron Ben-Horin, Ehud Mekori-Domachevsky
Summary: Depression and anxiety are common among inflammatory bowel disease (IBD) patients, affecting their quality of life and disease prognosis. This study demonstrates the utility of the Hospital Anxiety and Depression Scale (HADS) as a valid screening tool for depression and anxiety in IBD patients. Administering the HADS in gastrointestinal follow-ups with lower cut-off scores for depression can help identify patients at risk.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY
(2022)
Article
Multidisciplinary Sciences
Mikiyas Amare Getu, Panpan Wang, Eva Johanna Kantelhardt, Edom Seife, Changying Chen, Adamu Addissie
Summary: This study aimed to examine the validity and reliability of the EORTC QLQ-BR45 questionnaire among breast cancer patients in Ethiopia. The results showed that the questionnaire has good reliability and validity, and can be used to assess the quality of life of breast cancer patients.
SCIENTIFIC REPORTS
(2022)
Article
Psychology, Multidisciplinary
John B. Nezlek, Marzena Rusanowska, Pawel Holas, Izabela Krejtz
Summary: The present study conducted a confirmatory factor analysis on the Polish version of HADS with psychologically distressed but non-hospitalized participants, revealing two correlated measures of affectively focused distress, depression, and anxiety. However, caution should be taken by analysts and practitioners as there may be limitations in the discriminant validity of these two scales due to the correlation between the subscales and potential cross-loadings of items.
CURRENT PSYCHOLOGY
(2021)
Article
Psychology, Multidisciplinary
Patricia Toquero, Carmen Blanco Fernandez, Maria Pilar Lopez Marti, Berta Hernandez Marin, E. Beatriz Vera Cea, Ana Garrido Garcia, Elena Mendez Carrascosa, Dulce Banon Torres, Olga Donnay Candil, Ana Isabel Ballesteros Garcia, Jose Miguel Sanchez-Torres, Pablo Costas Rojo, Rebeca Mondejar, Ramon Colomer, Nuria Romero-Laorden
Summary: During the COVID-19 pandemic, high rates of emotional distress were detected among cancer patients in active treatment, with fear of cancer being greater than fear of COVID-19. Factors associated with higher psychological symptomatology included a history of psychotropic drug use and the adoption of extra infection prevention measures.
FRONTIERS IN PSYCHOLOGY
(2021)
Article
Medicine, General & Internal
Siming Jia, Chengbai Li, Zhuqing Lei, Qiang Xia, Yuqing Jiang
Summary: Studies have shown that patients with pheochromocytomas are more likely to experience anxiety and depression, hence early screening for these conditions should be recommended for future treatment to improve the mental health of the patients.
Article
Public, Environmental & Occupational Health
Ahmed N. Albatineh, Abdullah Al-Taiar, Reem Al-Sabah, Bashar Zogheib
Summary: The study evaluated the reliability and factor structure of the Arabic version of HADS in HD patients, indicating its suitability as a screening tool for depression and anxiety among Arabic HD patients. The findings suggest that the Arabic HADS has good reliability and internal consistency, with the three-factor structure showing a better fit for further exploration in psychological models for anxiety and depression in HD patients.
PSYCHOLOGY HEALTH & MEDICINE
(2021)
Article
Psychiatry
Carlos Arturo Cassiani-Miranda, Orlando Scoppetta, Diego Fernando Cabanzo-Arenas
Summary: This study assessed the validity of the Hospital Anxiety and Depression Scale (HADS) for screening depression and anxiety in primary care patients in Colombia. The results showed that HADS is a valid and reliable tool for screening depression and anxiety in the primary healthcare setting in Colombia.
GENERAL HOSPITAL PSYCHIATRY
(2022)
Article
Hematology
Simone Fischer, Christine Meisinger, Jakob Linseisen, Thomas M. Berghaus, Inge Kirchberger
Summary: Pulmonary embolism (PE) is a life-threatening event, and the emotional experience of patients is often overlooked. A study on PE patients revealed that about one-in-five patients experienced depressive or anxiety symptoms after PE. Factors such as age, history of depression, and pulmonary embolism severity index were associated with depression and anxiety symptoms. Monitoring the mental health of PE patients is important for early detection and intervention.
THROMBOSIS RESEARCH
(2023)
Article
Oncology
Aline Hajj, Roula Hachem, Rita Khoury, Souheil Hallit, Bashar ElJebbawi, Fady Nasr, Fadi El Karak, Georges Chahine, Joseph Kattan, Lydia Rabbaa Khabbaz
Summary: The study aimed to evaluate the level of anxiety and depression among breast cancer patients receiving chemotherapy, and found that cognitive impairment, sleep quality, marital status, specific gene polymorphisms, and medication intake were correlated with these psychological disorders.
Article
Oncology
Francisco Jose Sanchez-Torralvo, Victoria Contreras-Bolivar, Maria Ruiz-Vico, Jose Abuin-Fernandez, Inmaculada Gonzalez-Almendros, Manuel Barrios, Gabriel Olveira
Summary: Anxiety and depression are common issues among cancer patients, particularly those who are hospitalized. This study found that about half of hospitalized cancer patients may have symptoms of anxiety, and nearly half may have symptoms of depression. Furthermore, malnourished patients were more likely to experience anxiety and depression symptoms.
SUPPORTIVE CARE IN CANCER
(2022)
